MUC1 mucin in urological malignancy

[1] MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 48 (10) : 588 - 594

[2] Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2 [J]. NATURE MEDICINE, 1998, 4 (01) : 43 - 49

[3] Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7 [J]. JOURNAL OF IMMUNOTHERAPY, 1997, 20 (01): : 38 - 47

[4] SPECIFIC, MAJOR HISTOCOMPATIBILITY COMPLEX - UNRESTRICTED RECOGNITION OF TUMOR-ASSOCIATED MUCINS BY HUMAN CYTO-TOXIC T-CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) : 7159 - 7163

[5] BOYES SB, 1999, CLIN CANCER RES, V5, P1918

[6] BRAGA VMM, 1992, DEVELOPMENT, V115, P427

[7] Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies [J]. BLOOD, 1999, 93 (12) : 4309 - 4317

[8] An α2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas [J]. GLYCOBIOLOGY, 1999, 9 (12) : 1307 - 1311

[9] Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions [J]. VIRCHOWS ARCHIV, 2000, 436 (02) : 119 - 126

[10] HMFG-2 AS A PROGNOSTIC INDICATOR IN SUPERFICIAL BLADDER-CANCER [J]. JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (11) : 1191 - 1195

[1] MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 48 (10) : 588 - 594

[2] Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2 [J]. NATURE MEDICINE, 1998, 4 (01) : 43 - 49

[3] Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7 [J]. JOURNAL OF IMMUNOTHERAPY, 1997, 20 (01): : 38 - 47

[4] SPECIFIC, MAJOR HISTOCOMPATIBILITY COMPLEX - UNRESTRICTED RECOGNITION OF TUMOR-ASSOCIATED MUCINS BY HUMAN CYTO-TOXIC T-CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) : 7159 - 7163

[5] BOYES SB, 1999, CLIN CANCER RES, V5, P1918

[6] BRAGA VMM, 1992, DEVELOPMENT, V115, P427

[7] Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies [J]. BLOOD, 1999, 93 (12) : 4309 - 4317

[8] An α2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas [J]. GLYCOBIOLOGY, 1999, 9 (12) : 1307 - 1311

[9] Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions [J]. VIRCHOWS ARCHIV, 2000, 436 (02) : 119 - 126

[10] HMFG-2 AS A PROGNOSTIC INDICATOR IN SUPERFICIAL BLADDER-CANCER [J]. JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (11) : 1191 - 1195